Bausch + Lomb price target lowered to $17 from $18 at Stifel

Stifel analyst Thomas Stephan lowered the firm’s price target on Bausch + Lomb (BLCO) to $17 from $18 and keeps a Hold rating on the shares. The company’s top-line performance again was solid in Q4, posting in estimated fourth-straight quarter of double digit year-over-year organic growth, the analyst tells investors in a research note. The firm added that Q4 adjusted EBITDA was slightly below its estimate and the FY25 adjusted EBITDA guidance fell short, but the firm believes this was fairly well-telegraphed. Stifel added that long-term margin expansion visibility remains limited, and the adjusted EBITDA outlook is likely further clouded by potentially growing uncertainty around Miebo/Xiidra.